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http://dx.doi.org/10.1016/j.pedneo.2Deficiency of hypoxanthine phosphoribosyltransferase activity is a rare inborn error of purine
metabolism with subsequent uric acid overproduction and neurologic presentations. The diag-
nosis of LescheNyhan syndrome (LNS) is frequently delayed until self-mutilation becomes evi-
dent. We report the case of a boy aged 1 year and 10 months who was diagnosed with profound
global developmental delay, persistent chorea, and compulsive self-mutilation since the age of
1 year. Serial serum uric acid levels showed normal uric acid level, and the spot urine uric acid/
creatinine ratio was >2. The hypoxanthine phosphoribosyltransferase cDNA showed the dele-
tion of exon 6, and the boy was subsequently diagnosed to have LNS. He also had respiratory
distress due to pulmonary embolism documented by chest computed tomography scan. This
report highlights the need to determine the uric acid/creatinine ratio caused by increased
renal clearance in LNS in young children. The presence of pulmonary embolism is unusual
and may be the consequence of prolonged immobilization.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
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Lesch-Nyhan syndrome and pulmonary embolism 3131. Introduction recurrent airway infection and respiratory distress compli-LescheNyhan syndrome (LNS) is a genetic disorder of purine
salvage caused by a complete deficiency of hypoxanthine
phosphoribosyltransferase (HPRT) activity resulting from a
mutation in the corresponding gene on the long arm of the X
chromosome.1 Affected individuals usually suffer from
overproduction of uric acid that may lead to hyperuricemia
or nephrolithiasis.2 High serum uric acid level is usually the
biochemical finding that prompts special testing for the
specific diagnosis. However, infants with LNS may have
borderline serum uric acid levels because of an increased
renal clearance of uric acid.3 Diagnosis can be made by
clinical features and further confirmed by direct sequenc-
ing of all exons of the HPRT gene.4,5
Pulmonary embolism is more commonly found in adults
with underlying predisposing factors and conditions that
interfere with normal venous blood flow. In children, pul-
monary embolism is rare. The few reports about pediatric
pulmonary embolism reflect its relative rarity and difficult
evaluation.6 Imaging evaluation of pulmonary embolism is
crucial for diagnosis. The use of a multidetector computed
tomography (MDCT) shortens the time of the study and
greatly improves its resolution.7
2. Case Report
A boy aged 1 year and 10 months presented with devel-
opmental delay. He was born to nonconsanguineous healthy
parents, and had been diagnosed with nephrolithiasis at the
age of 5 months. When the patient was 6 months old,Figure 1 The pedigree and sequence amplified cDNA of the HPR
erozygous carrier.cated by laryngomalacia required repeated hospital
admission and central catheterization during hospital-
ization. He was diagnosed with profound psychomotor
retardation and was bed-ridden since 1 year of age. He also
had chorea when awake, and compulsive self-destructive
behavior such as biting fingers, lips, and buccal mucosa
were noted for about 6 months.
Laboratory tests showed normal complete blood count,
electrolytes, blood gas, ammonia, and lactate. Although
serial serum uric acid level showed normal uric acid level
(7.6 mg/dL), the spot urine uric acid/creatinine ratio was
116/50 or >2.0, which subsequently pointed to a diagnosis
of LNS. There were no particular findings on brain magnetic
resonance image and electroencephalography.
The patient and his family, as well as control individuals
were analyzed using multiplex quantitative polymerase
chain reaction (PCR) to amplify the FGFR2 gene, the KRIT1
gene, and the HPRT gene simultaneously. The HPRT cDNA,
amplified from the total RNA of the patient’s peripheral
blood by multiple specific primers for multiplex PCR,
showed the deletion of exon 6. The family study revealed
that the patient’s mother was a heterozygous carrier
(Figure 1). He was put on allopurinol for his uric acid
overproduction and nephrolithiasis.
Because of his persistent respiratory distress, the study
of chest MDCT with intravenous contrast injection was
performed. The images of chest MDCT showed pulmonary
embolism with nonobstructive lobar and segmental arterial
thrombi in the basal segments of the left lower lobe. This
may explain the persistent respiratory distress of the
patient (Figure 2).T gene in the patient (black). The patient’s mother is a het-
Figure 2 Chest images using a 320-MDCT (multidetector computed tomography) scanner with a nonhelical one-volume scan
mode. (A) Oblique coronal thin-slab maximum-intensity projection image shows a tubular filling defect (arrow) in the branch of the
left pulmonary artery in the left lower lobe. (B) 3D image using volume rendering techniques shows eccentric thinning of the
embolismic artery (arrow). The distal branches (arrowheads) of the left pulmonary artery are still patent.
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The diagnosis of LNS is frequently delayed until self-
mutilation becomes evident.8 It is the most striking fea-
ture of LNS and is only present in patients with the complete
enzyme defect, although some patients never show this type
of behavior. The self-mutilation associated with LNS typi-
cally first appears with the emergence of teeth, and steadily
worsens with increasing age.9 In the current patient, such
behavior prompted the investigation of his uric acid under
the suspicion of LNS. Patients with HPRT deficiency must be
confirmed by clinical, biochemical, enzymatic, and molec-
ular analyses. In this case, despite fulfilling the diagnosis
criteria of LNS, the patient’s serial serum uric acid only
showed normal uric acid. Thus, the uric acid/creatinine
ratio was used to corroborate the clinical diagnosis. In young
children, renal function is quite efficient in eliminating uric
acid into the bladder, and hence, they may have borderline
hyperuricemia due to increased renal clearance. As such,
the urinary uric acid/creatinine ratio can be used as a
screening test for inherited disorders of purine metabolism
based on the age of the patient. Values for the urinary ratio
should be <1.0 after the age of 3 years.10
The HPRT gene is localized to the Xq26 region, and the
complete amino acid sequence for HPRT is known to be
44 kb, which consists of nine exons with a coding for a
219-amino acid protein that converts hypoxanthine into
inosinic acid and guanine into guanylic acid. To date, more
than 300 disease-associated mutations in the HPRT gene
have been identified,5 but reports of LNS in Taiwan remains
limited. Mak et al11 reported a case series of four patients
with LNS from three families. Three patients in two families
were revealed to have novel missense mutation in exons 3
and 8, and in one patient, a splicing region of intron 4 of the
HPRT encoding region was reported. Hou12 reported a
9-year-old boy with LNS complicated with atlantoaxial
subluxation, and the direct genomic DNA sequencing of the
HPRT gene revealed a single nucleotide substitution in
intron 5. To the best of our knowledge, this is the first
case of LNS with exon 6 deletion reported in Taiwan.Treatment of LNS remains limited for self-mutilation and
motor syndrome. However, allopurinol should be started as
soon as the enzyme deficiency is diagnosed, although it has
no reported effect on behavioral and neurological symp-
toms. It should be adjusted to reduce hyperuricemia and
achieve a urinary uric acid/creatinine ratio lower than 1.0.
Allopurinol is efficacious and generally safe as treatment
for uric acid overproduction in patients with HPRT
deficiency.13
Pediatric patients rarely present with conditions that
place them at high risk for thrombus formation. When it
occurs, pulmonary embolism has been shown to cause
serious illness and even death. Traditional risk factors in
adults may be a consequence of continuous immobiliza-
tion,14 because the pathophysiology of thrombus formation
is blood flow stasis.15 Nonetheless, there is no article on LNS
that suggests the complication of pulmonary embolism, and
as such, it can be considered a consequence of long-term
immobilization stemming from his profound retardation
and recurrent central catheterization.
In conclusion, this report highlights the value of the uric
acid/creatinine ratio as a screening tool for young male
children highly suspected to have LNS. To the best of our
knowledge, this is the first case report of LNS associated
with pulmonary embolism, complicated by the patient’s
long-term immobilization.Conflicts of interest
The authors have no conflicts of interest relevant to this
article.References
1. Nyhan WL. Inherited hyperuricemic disorders. Contrib Nephrol
2005;147:22e34.
2. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism
and central nervous system function. Am J Med 1964;36:
561e70.
Lesch-Nyhan syndrome and pulmonary embolism 3153. Rinat C, Zoref-Shani E, Ben-Neriah Z, Bromberg Y, Becker-
Cohen R, Feinstein S, et al. Molecular, biochemical, and
genetic characterization of a female patient with
LescheNyhan disease. Mol Genet Metab 2006;87:249e52.
4. Jinnah HA, Harris JC, Nyhan WL, O’Neill JP. The spectrum of
mutations causing HPRT deficiency: an update. Nucleosides
Nucleotides Nucleic Acids 2004;23:1153e60.
5. Yamada Y, Nomura N, Yamada K, Wakamatsu N. Molecular
analysis ofHPRTdeficiencies: anupdateof the spectrumofAsian
mutations with novel mutations. Mol Genet Metab 2007;90:
70e6.
6. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M,
et al. Outcome of pediatric thromboembolic disease: a report
from the Canadian Childhood Thrombophilia Registry. Pediatr
Res 2000;47:763e6.
7. Schoepf UJ. Diagnosing pulmonary embolism: time to rewrite
the textbooks. Int J Cardiovasc Imaging 2005;21:155e63.
8. Nyhan WL. LescheNyhan disease. Nucleosides Nucleotides
Nucleic Acids 2008;27:559e63.
9. Anderson LT, Ernst M. Self-injury in LescheNyhan disease. J
Autism Dev Disord 1994;24:67e81.10. Kaufman JM, Greene ML, Seegmiller JE. Urine uric acid to
creatinine rtio e a screening test for inherited disorders
of purine metabolism. Phosphoribosyltransferase (PRT) defi-
ciency in X-linked cerebral palsy and in a variant of gout. J
Pediatr 1968;73:583e92.
11. Mak BS, Chi CS, Tsai CR, Lee WJ, Lin HY. New mutations of the
HPRT gene in LescheNyhan syndrome. Pediatr Neurol 2000;23:
332e5.
12. Hou JW. Atlantoaxial subluxation with recurrent consciousness
disturbance in a boy with LescheNyhan syndrome. Acta Pae-
diatr 2006;95:1500e4.
13. Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in
patients with hypoxanthineeguanine phosphoribosyltransfer-
ase deficiency. Metabolism 2007;56:1179e86.
14. Lee LC, Shah K. Clinical manifestation of pulmonary embolism.
Emerg Med Clin North Am 2001;19:925e42.
15. Dalen JE. Pulmonary embolism: what have we learned since
Virchow? Natural history, pathophysiology, and diagnosis.
Chest 2002;122:1440e56.
